flumazenil has been researched along with Muscle Weakness in 2 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
Muscle Weakness: A vague complaint of debility, fatigue, or exhaustion attributable to weakness of various muscles. The weakness can be characterized as subacute or chronic, often progressive, and is a manifestation of many muscle and neuromuscular diseases. (From Wyngaarden et al., Cecil Textbook of Medicine, 19th ed, p2251)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Justel, M | 1 |
| Jou, C | 1 |
| Sariego-Jamardo, A | 1 |
| Juliá-Palacios, NA | 1 |
| Ortez, C | 1 |
| Poch, ML | 1 |
| Hedrera-Fernandez, A | 1 |
| Gomez-Martin, H | 1 |
| Codina, A | 1 |
| Dominguez-Carral, J | 1 |
| Muxart, J | 1 |
| Hernández-Laín, A | 1 |
| Vila-Bedmar, S | 1 |
| Zulaica, M | 1 |
| Cancho-Candela, R | 1 |
| Castro, MDC | 1 |
| de la Osa-Langreo, A | 1 |
| Peña-Valenceja, A | 1 |
| Marcos-Vadillo, E | 1 |
| Prieto-Matos, P | 1 |
| Pascual-Pascual, SI | 1 |
| López de Munain, A | 1 |
| Camacho, A | 1 |
| Estevez-Arias, B | 1 |
| Musokhranova, U | 1 |
| Olivella, M | 1 |
| Oyarzábal, A | 1 |
| Jimenez-Mallebrera, C | 1 |
| Domínguez-González, C | 1 |
| Nascimento, A | 1 |
| García-Cazorla, À | 1 |
| Natera-de Benito, D | 1 |
| Echaniz-Laguna, A | 1 |
| Degos, B | 1 |
| Bonnet, C | 1 |
| Latour, P | 1 |
| Hamadouche, T | 1 |
| Lévy, N | 1 |
| Leheup, B | 1 |
2 other studies available for flumazenil and Muscle Weakness
| Article | Year |
|---|---|
Expanding the phenotypic spectrum of
Topics: Humans; Intellectual Disability; Microcephaly; Muscle Weakness; Muscular Dystrophies; Muscular Dystr | 2023 |
NDRG1-linked Charcot-Marie-Tooth disease (CMT4D) with central nervous system involvement.
Topics: Adolescent; Brain; Cell Cycle Proteins; Central Nervous System; Charcot-Marie-Tooth Disease; Deafnes | 2007 |